Thai PBS Thai PBS
Moderna, Novavax to produce more COVID-19 vaccines in S.Korea

Moderna, Novavax to produce more COVID-19 vaccines in S.Korea

13 Sept 12:27 Key points summarised by AI
  • Moderna and Novavax finalized agreements with the South Korean government to manufacture COVID-19 vaccines locally, addressing South Korea's urgent need for faster vaccine deliveries.
  • These deals stem from a comprehensive partnership between U.S. President Biden and South Korean President Moon, aiming to combine U.S. vaccine expertise with South Korean production capacity.
  • Moderna's vaccine will be produced by Samsung Biologics, while Novavax expands its collaboration with SK Bioscience, solidifying South Korea's emergence as a global vaccine manufacturing base.
  • The initiative supports South Korea's ambitious goal of inoculating at least 70% of its 52 million people by September, leveraging increased domestic production capabilities.
Read full article
World 1/2
Skip > Skip >